{"resourceType":"ValueSet","id":"2.16.840.1.113762.1.4.1116.32","meta":{"versionId":"4","lastUpdated":"2015-05-28T01:00:03.000-04:00"},"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.32","version":"20150528","name":"Hepatitis B Antigen Test","status":"active","date":"2015-05-28T01:00:03-04:00","publisher":"American Society of Clinical Oncology Steward","compose":{"include":[{"system":"http://www.ama-assn.org/go/cpt","version":"2021","concept":[{"code":"87340","display":"Infectious agent antigen detection by enzyme immunoassay technique, qualitative or semiquantitative, multiple-step method; hepatitis B surface antigen (HBsAg)"},{"code":"87341","display":"Infectious agent antigen detection by enzyme immunoassay technique, qualitative or semiquantitative, multiple-step method; hepatitis B surface antigen (HBsAg) neutralization"},{"code":"87516","display":"Infectious agent detection by nucleic acid (DNA or RNA); hepatitis B virus, amplified probe technique"},{"code":"87517","display":"Infectious agent detection by nucleic acid (DNA or RNA); hepatitis B virus, quantification"},{"code":"87912","display":"Infectious agent genotype analysis by nucleic acid (DNA or RNA); Hepatitis B virus"}]}]}}